Medpace Holdings, Inc.
Medpace Holdings, Inc. (Nasdaq: MEDP) is a clinical contract research organization that provides outsourced clinical development services to biotechnology, pharmaceutical and medical device companies. Its full-service offerings support clinical trials from Phase I through Phase IV, including study design and… From the company’s description.
In fiscal 2025, Medpace Holdings, Inc. reported revenue of $2.53B, up 20.0% from fiscal 2024, and net income of $451.12M. Its operating margin was 21.1%, and operations generated $713.22M in cash. Over the twelve months to Sep 30, 2026, revenue was $2.84B.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Medpace Holdings, Inc. does
In the company’s own words
Medpace Holdings, Inc. (Nasdaq: MEDP) is a clinical contract research organization that provides outsourced clinical development services to biotechnology, pharmaceutical and medical device companies. Its full-service offerings support clinical trials from Phase I through Phase IV, including study design and management, site start-up and monitoring, patient recruitment, regulatory affairs, data sciences, pharmacovigilance, laboratory testing and clinical pharmacology. Customers range from small and mid-sized biopharmaceutical companies to large pharmaceutical companies. Medpace operates as a single business focused on clinical development services, with expertise across therapeutic areas including oncology, metabolic disease, cardiology, infectious disease and central nervous system disorders. Its ClinTrak platform supports clinical trial management, while its laboratory and clinic services include central and bioanalytical testing, imaging, cardiovascular analysis and Phase I studies. The company has approximately 6,200 employees across 46 countries as of December 31, 2025. Its trademarks include Medpace, ClinTrak and Intellipace. Its website is www.medpace.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Professional Services
- Headquarters
- CINCINNATI, OH
- Fiscal year end
- December
- CIK
- 1668397
- SIC
- 8731
Financial performance, year by year
Fiscal 2016–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Medpace Holdings, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Superinvestors in Medpace Holdings, Inc. · what they did last quarter
Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.
Largest fund holders · Medpace Holdings, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Medpace Holdings, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Medpace Holdings, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Medpace Holdings, Inc.'s last four quarterly filings that the numbers alone won't show?”